Showing results (321-330 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|July 6, 2011
Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) databaseMaria Werner-Wasik, Rebecca Paulus, Walter J Curran, et al.
Clinical Lung Cancer|April 3, 2012
hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancerNa Cha, Xiao-Yan Li, Yu-Jie Zhao, et al.
Clinical Lung Cancer|May 10, 2011
History of small-cell lung cancerShadi Haddadin, Michael C Perry
Clinical Lung Cancer|May 10, 2011
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor sizeTom Donnem, Sigve Andersen, Samer Al-Saad, et al.
Clinical Lung Cancer|May 10, 2011
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213Elizabeth Gore, Kyounghwa Bae, Corey Langer, et al.
Clinical Lung Cancer|July 7, 2011
Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II studyAdnan Aydiner, Fatma Sen, Esra Kaytan Saglam, et al.
Clinical Lung Cancer|January 12, 2008
The evolving role of interventional pulmonary in the interdisciplinary approach to the staging and management of lung cancer. Part III: diagnosis and management of malignant pleural effusionsKen Y Yoneda, Praveen N Mathur, Stefano Gasparini
Clinical Lung Cancer|January 12, 2008
Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancersHirofumi Nakano, Hiroshi Soda, Yoichi Nakamura, et al.
Clinical Lung Cancer|January 12, 2008
A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamicsCesare Gridelli, Antonio Rossi, Floriana Morgillo, et al.
Clinical Lung Cancer|November 7, 2016
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore ApproachErna-Elise Paulsen, Thomas K Kilvaer, Mehrdad Rakaee Khanehkenari, et al.
Pageof 234